ERBB2 and breast carcinoma: For example, common pathways, including Notch, human epidermal growth factor receptor 2 (Her-2), NF-κB, and signal transducer and activator of transcription 3 (STAT-3), are targets of various treatmentoptions used against breast cancer [52].